Humana Inc.

$420.69$-4.73 (-1.11%)
Last updated on --.

Humana Inc. price

24 Hours-1.11%-$4.730
30 days+13.47%+$50.47
60 days+10.00%+$38.64
90 days+8.78%+$34.18

About Humana Inc.

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Stock ticker
HUM
Company
Humana Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
23
Launch date
Dec 31, 1981
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: HUM reported Revenue of 40.87B (+26.18%), beating expectations; EPS of 7.61 (+21.37%), beating expectations.

Revenue (USD)Beat40.87B+26.17%40.58B+27.32%286.85M+0.70%
EPS (USD)Beat7.61+21.37%7.27+22.80%0.34+4.67%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
4.511.62-6.619.835.72
-19.90%-59.30%-14.76%-4.57%+26.82%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
50.36B49.72B48.75B55.28B57.20B
32.06B31.14B31.01B36.63B37.92B
63.66%62.62%63.61%66.26%66.29%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.27B971.00M-1.65B1.25B-426.00M
+4.78%-47.74%-212.88%+278.85%-133.52%
● CFO● YoY

Shareholders

Shareholders
DODGE & COX9.10%
BLACKROCK, INC.8.66%
VANGUARD CAPITAL MANAGEMENT LLC6.52%
VANGUARD PORTFOLIO MANAGEMENT LLC4.84%
STATE STREET CORP4.53%
Others66.32%
Institutions
% Owned99.54%+3.74%
Shares held119.79M+4.50M
Institutions993+152
% OwnedPrice
Name% OwnedChange
DODGE & COX9.10%-440.29K
BLACKROCK, INC.8.66%+218.75K
VANGUARD CAPITAL MANAGEMENT LLC6.52%+4.86K
VANGUARD PORTFOLIO MANAGEMENT LLC4.84%+10.52K
STATE STREET CORP4.53%+4.08K

Dividends

Dividends
Last ex-dividend: Oct 30, 2026 Cash dividend: 0.89 USD per share
Dividend yield TTM
0.83%
Payout ratio LFY
35.97%
Frequency
Quarterly
20222023202420252026
3.153.543.543.542.66
+0.61%+0.77%+1.39%+1.36%+0.83%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Dec 31, 1981
DateRatio
Aug 1, 19912 → 3
Feb 1, 19845 → 6
Feb 1, 19833 → 4
Feb 1, 19822 → 3
Feb 3, 19811 → 2
Feb 1, 19803 → 4
Nov 2, 19782 → 3
Oct 24, 19772 → 3

Humana Inc. conversion tables

HUMHUM
USDUSD
0.5 HUM210.34 USD
1 HUM420.69 USD
5 HUM2,103.45 USD
10 HUM4,206.9 USD
USDUSD
HUMHUM
0.5 USD0.0011885 HUM
1 USD0.002377 HUM
5 USD0.011885 HUM
10 USD0.02377 HUM

More to explore

FAQ

HUM is trading at $420.69, -1.11% over the last 24 hours. Track live moves on the price chart at the top of this page.

The HUM stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HUM is currently trading at $420.69, -1.11% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HUM price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HUM's P/E ratio is currently 40.30 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HUM; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HUM's historical range and other companies in the Healthcare sector.

Humana Inc.'s market cap is currently 51.1B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.